http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 971 reviews. 971 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Eritromicin

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Eritromicin uses and description

Sort by popularity
Eritromicin - Pharmacology: Interferes with microbial protein synthesis.

Indication: Oral/IV

Treatment of infections of respiratory tract, skin and skin structure, and STDs caused by susceptible organisms; treatment of pertussis, diphtheria, erythrasma, intestinal amebiasis, conjunctivitis of newborn, Legionnaire disease, listeriosis, nongonococcal urethritis, pneumonia of infancy, urogenital infections during pregnancy; treatment of acute pelvic inflammatory disease, syphilis, and uncomplicated urethral, endocervical, or rectal infections in adults; prevention of attacks of rheumatic fever; prevention of bacterial endocarditis (IV).

Ophthalmic

Treatment of superficial ocular infections caused by strains of susceptible organism; prophylaxis of neonatal conjunctivitis.

Topical

Treatment of acne vulgaris.

Unlabeled UsesEritromicin stearate oral

Treponema pallidum, Campylobacter jejuni, Lymphogranuloma venereum, Haemophilus ducreyi (chancroid), administration prior to elective colorectal surgery to reduce wound complications, anthrax, Vincents gingivitis, erysipeloid, tetanus, actinomycosis, Nocardia infection, Eikenella corrodens infections, Borrelia infections (including early Lyme disease).

Eritromicin estolate oral

Acne vulgaris, bacillary angiomatosis in immunocompromised patients, campylobacter enteritis, erysipelas cellulitis, chancroid, granuloma inguinale, impetigo, ecthyma, inclusion conjunctivitis in adults, extremity infected wounds, leptospirosis, early Lyme disease, lymphogranuloma venereum, relapsing fever, tetanus.

Used for: Treating infections caused by certain bacteria. It is also used to prevent attacks of rheumatic fever in certain patients. It may also be used for other conditions as determined by your doctor.

Eritromicin is a macrolide antibiotic. It works by killing or slowing the growth of sensitive bacteria.

Macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. It is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

Eritromicin is produced by a strain of Streptomyces erythraeus and belongs to the macrolide group of antibiotics. After absorption, Eritromicin diffuses readily into most body fluids. In the absence of meningeal inflammation, low concentrations are normally achieved in the spinal fluid, but the passage of the drug across the blood-brain barrier increases in meningitis. Eritromicin is excreted in breast milk. The drug crosses the placental barrier with fetal serum drug levels reaching 5 - 20% of maternal serum concentrations. Eritromicin is not removed by peritoneal dialysis or hemodialysis.

Indications:

  • if you are allergic to erythromycin
  • if you are pregnant
  • if you are breast-feeding

  • Eritromicin belongs to a group of antibiotics called macrolides. Eritromicin works by disturbing the production of proteins by the bacteria. Due to the binding to the 50S subunits of the ribosome, Eritromicin inhibits the activity of the enzyme called peptidetranslocase. As a result, bacteria become incapable to form proteins. This is eventually fatal for the bacteria. Eritromicin acts on gram-positive bacteria including Streptococcus pneumoniae, Streptococcus spp., Bacillus anthracis, Clostridium spp., Corinebacterium diphtheriae. Most of the gram-negative bacteria are not susceptible to Erythromycin.

    Indications:

  • Diphtheria
  • Pertussis
  • Trachoma
  • Brucellosis
  • Legionnaires disease
  • Tonsillitis
  • Scarlet fever
  • Otitis
  • Sinusitis
  • Cholecystitis
  • Pneumonia
  • Gonorrhea
  • St. Job\'s disease

  • Eritromicin (Kojar) (EES) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. EES can also be used to prevent infection when you undergo certain dental procedures. EES belongs to a group of antibiotics called the macrolides.

    Eritromicin (Kojar) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Kojar) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Kojar) belongs to a group of antibiotics called the macrolides.

    Eritromicin (Kingdom) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Kingdom) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Kingdom) belongs to a group of antibiotics called the macrolides.

    Indications:

    Adult: PO Susceptible infections 1-2 g/day. Severe: Up to 4 g/day. Acne 250 mg/day. Severe: Up to 500 mg twice daily. Prophylaxis against pneumococcal infections; Prevention of streptococcal infections in patients w/ rheumatic fever or heart disease 250 mg twice daily. IV Susceptible infections As lactobionate: 15-20 mg/kg/day. Severe: Up to 4 g/kg/day. Ophth Ophth infections As 0.5% oint: Apply up to 6 times/day. Topical Acne As 2% gel/soln: Apply 1-2 times/day.

    Eritromicin (Yung Shin) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Yung Shin) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Yung Shin) belongs to a group of antibiotics called the macrolides.

    Oral Susceptible infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Severe campylobacter enteritis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Pertussis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Trench fever

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Chanroid

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Chlamydial infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Diphtheria

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Legionnaire\'s disease

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Pneumonia

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Sinusitis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Bronchitis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Acne

    Adult:

    Maintenance: 250 mg daily. Severe cases may require up to 500 mg bid.

    Child: Maintenance dose: 250 mg daily, up to 500 mg bid may be used in those >12 yr. For infants with acne, 250 mg daily in 1 or 2 divided doses may be used. Renal impairment: Severe impairment: Max dose of 1.5 g daily. Oral Prophylaxis against pneumococcal infections

    Adult: For patients who are unable to take penicillins or sulfonamides: 250 mg bid.

    Child: For patients who are unable to take penicillins or sulfonamides: 1 mth-2 yr: 125 mg bid; for older children: 250 mg bid. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Oral Prophylaxis of streptococcal infections in patients with evidence of rheumatic fever or heart disease

    Adult: For patients who are unable to take penicillins or sulfonamides: 250 mg bid.

    Child: For patients who are unable to take penicillins or sulfonamides: 1 mth-2 yr: 125 mg bid; for older children: 250 mg bid. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Intravenous Susceptible infections

    Adult: As lactobionate: 15-20 mg/kg/day, up to 4 g/kg/day in severe infections. May be given as a continuous or 6-hrly intermittent infusion over 20-60 minutes. Replace with oral Eritromicin as soon as possible. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Ophthalmic Treatment and prophylaxis of ophthalmic infections

    Adult: As 0.5% ophthalmic ointment: Apply to the affected eye(s) up to 6 times daily. Ophthalmic Treatment and prophylaxis of neonatal conjunctivitis

    Child: and neonate: As 0.5% ophthalamic ointment: Apply approximately 1 cm in length into each of the lower conjunctival sac, up to 2-6 times daily depending on the severity of the infection. Topical/Cutaneous Acne

    Adult: As 2% gel/solution: Apply onto affected areas 1-2 times daily. Discontinue treatment if condition worsens or if there is no improvement after 6-8 wk of continuous usage.

    Eritromicin belongs to a group of antibiotics called the macrolides. Eritromicin gel is used to treat acne, which is also commonly known as pimples. Eritromicin kills the bacteria in the skin which causes acne.

    Eritromicin (Union) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Union) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Union) belongs to a group of antibiotics called the macrolides.

    Oral Susceptible infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Severe campylobacter enteritis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Sinusitis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Bronchitis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Pertussis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Legionella Infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Trench fever

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Susceptible infections in penicillin-allergic patients

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral As alternative to tetracyclines for chlamydial infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Chanroid

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Diphtheria

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Pneumonia

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Acne

    Adult:

    Maintenance: 250 mg daily. Severe cases may require up to 500 mg bid.

    Child: Maintenance dose: 250 mg daily, up to 500 mg bid may be used in those >12 yr. For infants with acne, 250 mg daily in 1 or 2 divided doses may be used. Renal impairment: Severe impairment: Max dose of 1.5 g daily. Oral Prophylaxis against pneumococcal infections

    Adult: For patients who are unable to take penicillins or sulfonamides: 250 mg bid.

    Child: For patients who are unable to take penicillins or sulfonamides: 1 mth-2 yr: 125 mg bid; for older children: 250 mg bid. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Oral Prevention of streptococcal infections in patients with evidence of rheumatic fever or heart disease

    Adult: For patients who are unable to take penicillins or sulfonamides: 250 mg bid.

    Child: For patients who are unable to take penicillins or sulfonamides: 1 mth-2 yr: 125 mg bid; for older children: 250 mg bid. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Intravenous Susceptible infections

    Adult: As lactobionate: 15-20 mg/kg/day, up to 4 g/kg/day in severe infections. May be given as a continuous or 6-hrly intermittent infusion over 20-60 minutes. Replace with oral Eritromicin as soon as possible. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Ophthalmic Treatment and prophylaxis of eye infections

    Adult: As 0.5% ophthalmic ointment: Apply to the affected eye(s) up to 6 times daily. Ophthalmic Prophylaxis and treatment of neonatal conjunctivitis

    Child: and neonate: As 0.5% ophthalamic ointment: Apply approximately 1 cm in length into each of the lower conjunctival sac, up to 2-6 times daily depending on the severity of the infection. Topical/Cutaneous Acne

    Adult: As 2% gel/solution: Apply onto affected areas 1-2 times daily. Discontinue treatment if condition worsens or if there is no improvement after 6-8 wk of continuous usage.

    Eritromicin (Lin Chemical) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Lin Chemical) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Lin Chemical) belongs to a group of antibiotics called the macrolides.

    Eritromicin (C.I.) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (C.I.) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (C.I.) belongs to a group of antibiotics called the macrolides.

    Oral Susceptible infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Severe campylobacter enteritis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Pertussis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Trench fever

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Chanroid

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Chlamydial infections

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Diphtheria

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Legionnaire\'s disease

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Pneumonia

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Sinusitis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Bronchitis

    Adult: 1-2 g daily, increased up to 4 g daily for severe infections. Doses >1 g should be given in more than 2 divided doses.

    Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases; 2-8 yr: 1 g daily in divided doses; <2 yr: 500 mg daily in divided doses. Renal impairment: Severe impairment: Max: 1.5 g daily. Oral Acne

    Adult:

    Maintenance: 250 mg daily. Severe cases may require up to 500 mg bid.

    Child: Maintenance dose: 250 mg daily, up to 500 mg bid may be used in those >12 yr. For infants with acne, 250 mg daily in 1 or 2 divided doses may be used. Renal impairment: Severe impairment: Max dose of 1.5 g daily. Oral Prophylaxis against pneumococcal infections

    Adult: For patients who are unable to take penicillins or sulfonamides: 250 mg bid.

    Child: For patients who are unable to take penicillins or sulfonamides: 1 mth-2 yr: 125 mg bid; for older children: 250 mg bid. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Oral Prophylaxis of streptococcal infections in patients with evidence of rheumatic fever or heart disease

    Adult: For patients who are unable to take penicillins or sulfonamides: 250 mg bid.

    Child: For patients who are unable to take penicillins or sulfonamides: 1 mth-2 yr: 125 mg bid; for older children: 250 mg bid. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Intravenous Susceptible infections

    Adult: As lactobionate: 15-20 mg/kg/day, up to 4 g/kg/day in severe infections. May be given as a continuous or 6-hrly intermittent infusion over 20-60 minutes. Replace with oral Eritromicin as soon as possible. Renal impairment:

    Adult: Severe impairment: Max: 1.5 g daily. Ophthalmic Treatment and prophylaxis of ophthalmic infections

    Adult: As 0.5% ophthalmic ointment: Apply to the affected eye(s) up to 6 times daily. Ophthalmic Treatment and prophylaxis of neonatal conjunctivitis

    Child: and neonate: As 0.5% ophthalamic ointment: Apply approximately 1 cm in length into each of the lower conjunctival sac, up to 2-6 times daily depending on the severity of the infection. Topical/Cutaneous Acne

    Adult: As 2% gel/solution: Apply onto affected areas 1-2 times daily. Discontinue treatment if condition worsens or if there is no improvement after 6-8 wk of continuous usage. Special Populations: Max dose in patients with renal impairment: 1.5 g daily.

    Eritromicin (Central) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Central) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Central) belongs to a group of antibiotics called the macrolides.

    Eritromicin (Wah Foo) is an antibiotic. It is used to treat certain bacterial infections of the gut, ear, nose, throat, lungs or skin. It is also used to treat sexually-transmitted diseases such as gonorrhoea and syphilis. Eritromicin (Wah Foo) can also be used to prevent infection when you undergo certain dental procedures. Eritromicin (Wah Foo) belongs to a group of antibiotics called the macrolides.

    Eritromicin Bryntsalov-A is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Bryntsalov-A is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Morton Grove Pharmaceuticals is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Morton Grove Pharmaceuticals is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Purepac Pharmaceuticals is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Purepac Pharmaceuticals is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Abbott is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Abbott is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Parke-Davis is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Parke-Davis is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Stiefel Laboratories is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Stiefel Laboratories is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Clay-Park Laboratories is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Clay-Park Laboratories is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Sti-Med-Sorb is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Sti-Med-Sorb is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Mayne Pharma is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Mayne Pharma is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Naska is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Naska is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Meta Pharmaceuticals is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Meta Pharmaceuticals is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Aliud Pharma is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Aliud Pharma is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Fougera is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Fougera is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Nycomed is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Nycomed is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Bausch and Lomb is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Bausch and Lomb is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Polfa Tarchomin is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Polfa Tarchomin is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Merck is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Merck is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Sandoz is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Sandoz is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Dista is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Dista is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin PharmaDerm is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin PharmaDerm is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Quad Pharmaceuticals is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Quad Pharmaceuticals is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Paddock Laboratories is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Paddock Laboratories is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Ratiopharm is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Ratiopharm is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Acis Arzneimittelvertrieb is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Acis Arzneimittelvertrieb is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Sicor Pharmaceuticals is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Sicor Pharmaceuticals is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Biohimik is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Biohimik is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Tatchempharmpreparaty is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Tatchempharmpreparaty is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Eli Lilly is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Eli Lilly is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Dr. August Wolff Arzneimittel is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Dr. August Wolff Arzneimittel is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Elkins Sinn is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Elkins Sinn is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Lederle is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Lederle is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Nizhpharm is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Nizhpharm is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Stada is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Stada is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Shchelkovo Vitamin Plant is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Shchelkovo Vitamin Plant is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Akorn is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Akorn is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Genericon Pharma is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Genericon Pharma is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Novopharm is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Novopharm is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Biosynthesis is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Biosynthesis is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also active against Mycoplasma spp., Chlamydia spp., Spirochaetaceae, Rickettsia spp. To Eritromicin resistant gram-negative bacilli, including Escherichia coli, Pseudomonas aeruginosa, Shigella spp., Salmonella spp.

    Eritromicin Curasan is a macrolide antibiotic. Has bacteriostatic action. However at higher doses against susceptible organisms has a bactericidal effect. Eritromicin is reversibly bound to the ribosome of bacteria, thereby inhibiting protein synthesis. Eritromicin Curasan is active against gram-positive bacteria: Staphylococcus spp. (strains producing and not producing penicillinase), Streptococcus spp. (including Streptococcus pneumoniae); gram-negative bacteria: Neisseria gonorrhoeae, Haemophilus influenzae, Bordetella pertussis, Brucella spp., Legionella spp., Bacillus anthracis, Corynebacterium diphtheriae; anaerobic bacteria: Clostridium spp. Eritromicin is also acti

    Poultry: For oral treatment and prevention of C.R.D. synovitis, Coryza., Mycoplasma infections, infectious Bronchitis and after vaccination. Calves, Horses & Sheep: For the treatment of respiratory tract infections ( e.g. pneumonia, pharyngitis and Bronchitis).

    Susceptible infections,Severe campylobacter enteritis,Pertussis,Diphtheria,Chanroid,Legionnaire’s disease,Chlamydial infections,Legionnaire’s disease,Bronchitis,Pneumonia,Sinusitis,Trench fever,Acne,Prophylaxis of streptococcal infections in patients with evidence of rheumatic fever or heart disease,Treatment and prophylaxis of neonatal conjunctivitis.

    Eritromicin has a range of antibacterial actvity similar to that of penicilin.

    Poultry: Infectious coryza, infectious synovitis, Mycoplasmosis, Pasteurellosis, Staphylococcal arthritis and Streptococcal infections. Turkey: Air sacculitis, erysipelas, infectious sinusitis staphylococcal arthritis and streptococcal infections.

    Active ingredients: Erythromycin
    Unit description, dosagePrice, USD

    List of eritromicin brand and generic drugs

    Eritromed (Argentina)
    Eritromicin Belupo (Bosnia & Herzegowina, Croatia (Hrvatska))
    Eritromicin Hemofarm (Bosnia & Herzegowina)
    Eritromicin Jugoremedija (Bosnia & Herzegowina)
    Eritromicin Srbolek (Bosnia & Herzegowina)
    Eritromicina AC Farma (Peru)
    Eritromicina Afom (Italy)
    Eritromicina Andromaco (Chile)
    Eritromicina Atlas (Argentina)
    Eritromicina Cibran (Brazil)
    Eritromicina Colmed (Colombia)
    Eritromicina Dr. Collado (Dominican Republic)
    Eritromicina E.S. MK (Colombia)
    Eritromicina Elea (Argentina)
    Eritromicina Estearato Induquimica (Peru)
    Eritromicina Estedi (Spain)
    Eritromicina Etilsuccinato (Italy)
    Eritromicina Etilsuccinato Induquimica (Peru)
    Eritromicina Etilsuccinato L.CH. (Chile)
    Eritromicina Etilsuccinato Quilab (Peru)
    Eritromicina Fabra (Argentina)
    Eritromicina Farmindustria (Peru)
    Eritromicina G&R (Peru)
    Eritromicina Genfar (Colombia, Peru)
    Eritromicina IDI (Italy)
    Eritromicina Infarmasa (Peru)
    Eritromicina Klonal (Argentina)
    Eritromicina La Santé (Colombia)
    Eritromicina Lafedar (Argentina)
    Eritromicina Larjan (Argentina)
    Eritromicina lattobionato (Italy)
    Eritromicina Medifarma (Peru)
    Eritromicina Mintlab (Chile)
    Eritromicina MK (Colombia)
    Eritromicina Naturgen (Peru)
    Eritromicina Sandoz (Romania)
    Eritromicina Terbol (Peru)
    Eritromicina Tiocianato (Italy)
    Eritromicin√£ (Romania)
    Eritromin (Peru)

    Show all Eritromicin generic names
     
    Privacy Policy
    © 2003 - 2014 igenericdrugs.com All Rights Reserved
     
    Disclamer